Use of antipsychotics and risk of breast cancer: A Danish nationwide case-control study.

CONCLUSIONS: Overall, our results do not suggest a clinically important association between antipsychotic use and risk of breast cancer. The importance of drug-induced prolactin elevation is unclear but may lead slightly increased risk of estrogen receptor positive breast cancer. PMID: 29858518 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29858518?dopt=Abstract

Source: Clinical Breast Cancer - June 1, 2018 Category: Cancer & Oncology Authors: Pottegård A, Lash TL, Cronin-Fenton D, Ahern TP, Damkier P Tags: Br J Clin Pharmacol Source Type: research